RT @jmschott
My take on Lecanemab — how we got here, what we know, what it might mean for the NHS, and why more research in dementia is needed ⁦@AlzResearchUK⁩ ⁦@guardian⁩ ⁦@UKDRI⁩ ⁦@uclnews⁩ https://www.theguardian.com/commentisfree/2022/nov/30/alzheimers-drug-lecanemab-trials-nhs